氧化氨酸度与其在患有类风湿性关节炎的日本患者的疗效和安全性之间的关联
Hiroshi Takei1, Masayuki Hashiguchi2, Satoshi Takanashi1
1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan.
Modern rheumatology
|March 25, 2025
概括
氧化 (HCQ) 和其代谢物,特别是甲基氧化 (DHCQ) 和双甲基 (BCQ) 的较高血清水平与日本风湿性关节炎患者治疗HCQ的改善临床疗效相关.
科学领域:
- 药理学 药理学是指药理学的学科.
- 类风湿病学 类风湿病学
- 临床化学 临床化学
背景情况:
- 风湿性关节炎 (RA) 管理通常涉及疾病修饰性抗风湿药物 (DMARDs).
- 氧化 (HCQ) 是一种广泛用于治疗RA的合成DMARD.
- 了解HCQ血清水平与治疗结果之间的关系对于优化治疗至关重要.
研究的目的:
- 研究HCQ及其主要代谢物 (DHCQ,DCQ,BCQ) 的血清度与临床疗效之间的关联.
- 为了确定特定代谢物水平是否与在日本RA患者中达到美国风湿学会 (ACR) 响应标准的相关性.
主要方法:
- 一项涉及日本RA患者的前性研究,这些患者接受了HCQ治疗24周.
- 血清中HCQ及其衍生物 (DHCQ,DCQ,BCQ) 的度被连续测量.
- 统计分析将血清水平与ACR 20,50 和 70 响应率相关联.
主要成果:
- 在第四周,HCQ及其代谢物的血清度达到稳定水平.
- 实现ACR20的患者在24周内血清中HCQ,DHCQ,DCQ和BCQ度较高.
- 更高的DHCQ和BCQ水平与ACR50和ACR70反应有显著的关联.
结论:
- 血清中HCQ及其衍生物的度与日本RA患者的临床有效性有关.
- 特定的代谢物,DHCQ和BCQ,与更高水平的临床反应有更强的关联.
- 对HCQ代谢物的治疗药物监测可能有助于优化RA治疗.
相关概念视频
01:20The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
01:14Time Course of Drug Effect
1.8K
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50...
1.8K
01:22Dose-Response Relationship: Potency and Efficacy
4.1K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.1K
01:19Pharmacovigilance
761
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
761
01:31Factors Affecting Renal Clearance: Drug's Physicochemical Properties and Plasma Levels
150
Renal clearance of a drug is influenced by various factors, including its physicochemical properties and plasma levels. These factors play a significant role in determining how efficiently the kidneys eliminate a drug.
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
One important factor is the drug's molecular size. The kidneys readily excrete smaller molecules below 300 Daltons (Da). On the other hand, molecules weighing between 300 and 500 Da are excreted through both urine and bile. Larger molecules above 500 Da tend to be excreted...
150
01:15Drug Concentration Versus Time Correlation
561
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
561